Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study.
- Conditions
- Acute Myocardial Infarction
- Interventions
- Device: angio-guided thrombus aspiration (Eliminate catheter, Terumo, Tokyo, Japan)Device: OCT-guided thrombus aspiration (Eliminate catheter, Terumo, Tokyo, Japan)
- Registration Number
- NCT01914055
- Lead Sponsor
- Ospedale San Donato
- Brief Summary
demonstrate that FD-OCT guidance is feasible and possibly results in reduction of frequency-domain Optical Coherence Tomography-defined residual thrombus burden after thrombus-aspiration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- ST elevation myocardial infarction
- Ages Eligible for Study: >18 years old
- Genders Eligible for Study: Both (female sex with child-bearing potential excluded)
- occluded (TIMI 0) or sub occluded (TIMI 1) proximal vessel of estimated diameter ≥3mm
- intended use of thrombus aspiration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description angio-guided thrombus aspiration angio-guided thrombus aspiration (Eliminate catheter, Terumo, Tokyo, Japan) thrombus aspiration guided by angiography OCT-guided thrombus aspiration OCT-guided thrombus aspiration (Eliminate catheter, Terumo, Tokyo, Japan) thrombus aspiration guided by optical coherence tomography
- Primary Outcome Measures
Name Time Method number of cross-sections with thrombus area more than 10% at post-stenting frequency-domain (FD) Optical Coherence Tomography within the primary PCI procedure Whether FD-OCT guidance of manual thrombus aspiration (TA) is superior to conventional angio-guided TA in reducing residual thrombus burden after stenting (defined as the number of cross-sections with thrombus area more than 10% at post-stenting FD-OCT)
- Secondary Outcome Measures
Name Time Method major adverse cardiac events at 6 months rate of major adverse cardiac events at 6 months from the index procedure
Trial Locations
- Locations (1)
Cardiovascular Department, Ospedale S.Donato
🇮🇹Arezzo, AR, Italy